A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 4, 1997, Pages 1020-1026

  Kotlar, T J ^a   Young, R H ^b   Albanese, C ^a   Crowley Jr , W F ^b   Scully, R E ^b   Jameson, J L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; FOLLITROPIN; FOLLITROPIN RECEPTOR; LUTEINIZING HORMONE RECEPTOR;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; OVARY CARCINOMA; OVARY TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX CORD TUMOR;

ADOLESCENT; ADULT; ANIMALS; CHILD; CHILD, PRESCHOOL; COS CELLS; CYCLIC AMP; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INFANT; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; RECEPTORS, FSH; RECEPTORS, LH; SEX CORD-GONADAL STROMAL TUMORS;

EID: 0030946771     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.4.1020     Document Type: Article

References (37)

1. Young RH, Scully RE. 1992 Endocrine tumors of the ovary. Curr Top Pathol. 85:114-164.
2. Scully RE. 1995 Ovarian tumors with endocrine manifestations. In: DeGroot LJ (ed) Endocrinology. Philadelphia: Saunders; 2113-2139.
3. Healy DL, Burger HG, Mamers P, et al. 1993 Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med. 329:1539-1542.
4. Jobling T, Mamers P, Healy DL, et al. 1994 A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol Oncol. 55:285-289.
5. Gustafson ML, Lee MM, Scully RE, et al. 1992 Mullerian inhibiting substance as a marker for ovarian sex-cord tumor. N Engl J Med. 326:466-471.
6. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. 1992 Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 360:313-319.
7. Shikone T, Matzuk MM, Perlas E, et al. 1994 Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor. Mol Endocrinol. 8:983-995.
8. Matzuk MM, Kumar R, Shou W, et al. 1996 Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog Horm Res. 51:123-157.
9. Taguchi O, Michael SD, Nishizuka Y. 1988 Rapid induction of ovarian granulosa cell tumors by 7,12-dimethylbenz(a)anthracene in neonatally estrogenized mice. Cancer Res. 48:425-429.
10. Brisigotti M, Fabbretti G, Pesce F, et al. 1993 Congenital bilateral juvenile granulosa cell tumor of the ovary in leprechaunism: a case report. Pediatr Pathol. 13:549-558.
11. Roush GR, el-Naggar AK, Abdul-Karim FW. 1995 Granulosa cell tumor of ovary: a clinicopathologic and flow cytometric DNA analysis. Gynecol Oncol. 56:430-434.
12. Shashi V, Golden WL, von Kap-Herr C, Andersen WA, Gaffey MJ. 1994 Interphase fluorescence in situ hybridization for trisomy 12 on archival ovarian sex cord-stromal tumors. Gynecol Oncol. 55:349-354.
13. Nakano R, Kitayama S, Yamoto M, Shima K, Ooshima A. 1989 Localization of gonadotropin binding sites in human ovarian neoplasms. Am J Obstet Gynecol. 161:905-910.
14. Willemsen W, Kruitwagen R, Bastiaans B, Hanselaar T, Rolland R. 1993 Ovarian stimulation and granulosa-cell tumour. Lancet. 341:986-988.
15. Gocze PM, Freeman DA, Arany A, Garadnay B. 1993 Ovarian stimulation and granulosa-cell tumour. Lancet. 341:1346.
16. Jansen R. 1993 Ovarian stimulation and granulosa-cell tumour. Lancet. 341:1345.
17. Shenker A, Laue L, Kosugi S, Merendino Jr JJ, Minegishi T, Cutler Jr GB. 1993 A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature. 365:652-654.
18. Parma J, Duprez L, Van Sande J, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
19. Shenker A. 1995 G protein-coupled receptor structure and function: the impact of disease-causing mutations. Bailliere Clin Endocrinol Metab. 9:427-451.
20. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G. 1995 Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab. 80:2577-2585.
21. Aittomaki K, Lucena JL, Pakarinen P, et al. 1995 Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 82:959-968.
22. Kremer H, Kraaij R, Toledo SP, et al. 1995 Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet. 9:160-164.
23. Latronico AC, Anasti J, Amhold IJ, et al. 1995 A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab. 80:2490-2494.
24. Latronico AC, Anasti J, Arnhold IJ, et al. 1996 Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med. 334:507-512.
25. Gromoll J, Simoni M, Nieschlag E. 1996 An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab. 81:1367-1370.
26. Goelz SE, Hamilton SR, Vogelstein B. 1985 Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun. 130:118-126.
27. Karga H, Lee JK, Vickery Jr AL, Thor A, Gaz RD, Jameson JL. 1991 ras oncogene mutations in benign and malignant thyroid neoplasms. J Clin Endocrinol Metab. 73:832-836.
28. Albanese C, Christin-Maitre S, Sluss PM, Crowley WF, Jameson JL. 1994 Development of a bioassay for FSH using a recombinant human FSH receptor and a cAMP responsive luciferase reporter gene. Mol Cell Endocrinol. 101:211-219.
29. Schneyer AL, Sluss PM, Bosukonda D, Reichert Jr LE. 1986 Electrophoretic purification of radioiodinated follicle-stimulating hormone for radioligand receptor assay, and radioimmunoassay. Endocrinology. 119:1446-1453.
30. Rose JK, Buonocore L, Whitt MA. 1991 A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques. 10:520-525.
31. Clement PB, Young RH, Hanna W, Scully RE. 1994 Sclerosing peritonitis associated with luteinized thecomas of the ovary. Am J Surg Pathol. 18:1-13.
32. Young RH, Oliva E, Scully RE. 1994 Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol. 18:1102-1116.
33. Means AR, Dedman JR, Tash JS, Tindall DJ, van Sickle M, Welsh MJ. 1980 Regulation of the testis sertoli cell by follicle stimulating hormone. Annu Rev Physiol. 42:59-70.
34. Knecht M, Amsterdam A, Catt K. 1981 The regulatory role of cyclic AMP in hormone-induced granulosa cell differentiation. J Biol Chem. 256:10628-10633.
35. Hipkin RW, Liu X, Ascoli M. 1995 Truncation of the C-terminal tail of the follitropin receptor does not impair the agonist- or phorbol ester-induced receptor phosphorylation and uncoupling. J Biol Chem. 270:26683-26689.
36. Inglese J, Freedman NJ, Koch WJ, Lefkowitz RJ. 1993 Structure and mechanism of the G protein-coupled receptor kinases. J Biol Chem. 268:23735-23738.
37. Kosugi S, Okajima F, Ban T, Hidaka A, Shenker A, Kohn LD. 1993 Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3′,5′-cyclic adenosine monophosphate signal generation. Mol Endocrinol. 7:1009-1020.